Above Food Ingredients Inc. (ABVEW) Análisis de acciones

Descripción de la empresa

Above Food Ingredients Inc. operates as a regenerative ingredient company that maintains a vertically integrated supply chain to produce products across Canada, the United States, Mexico, China, France, Turkey, and international markets. The enterprise functions within sectors and industries designated as not applicable (N/A) in standard classification databases, which suggests a specialized operational model that may not align with traditional industry categorizations. The company's scale is defined by an annual revenue of $294.84 million, while its market capitalization and employee count are currently listed as not available. These financial metrics indicate a substantial revenue base relative to its reported lack of market cap data, potentially reflecting a capital structure or listing status that does not fully correlate with its operational scale or suggesting significant equity dilution or restructuring factors not captured in standard market cap calculations. The absence of specific employee count data further limits the ability to gauge operational headcount efficiency directly against revenue, though the revenue figure alone places the firm in a mid-to-large cap operational tier within the food ingredients landscape.

Salud financiera

The company reported a trailing twelve-month revenue of $294.84 million, yet this generated a net income of -$61,292,864 and an EBITDA of -$40,343,004, revealing a significant divergence between top-line sales and bottom-line profitability. This substantial gap between revenue and net income indicates a cost structure where operating expenses and taxes far exceed gross profits, resulting in a net loss that is more than 50% larger in magnitude than the reported EBITDA loss. Although free cash flow data is not available, the negative EBITDA combined with a cash balance of $664,430 suggests limited financial flexibility to fund operations or capital expenditures without external financing. The gross margin stands at -2.8%, the operating margin at -23.3%, and the profit margin at -23.4%, all of which are negative figures indicating that the company is losing money on every dollar of sales before interest and taxes, and ultimately on every dollar of revenue after all expenses including interest and taxes. When comparing total cash of $664,430 against total debt of $133.84 million, the liquidity position appears precarious given the debt load, although the specific debt-to-equity ratio is listed as not available. The current ratio is 0.23, which indicates a severe short-term liquidity constraint where current liabilities significantly exceed current assets, raising concerns about the ability to meet obligations due within a year. Furthermore, the return on equity and return on assets are listed as not available, preventing a direct quantitative assessment of management effectiveness in generating returns on shareholder and asset bases, though the negative net income inherently implies negative returns on these capital inputs.

Evaluación de valoración

The trailing P/E ratio and forward P/E ratio are both listed as not available, which precludes a standard comparison of valuation multiples but implies that earnings are not yet positive enough to support a meaningful price-to-earnings multiple. The price-to-book ratio is recorded at -0.54, a negative figure that indicates the market value of the equity is below the book value, a situation often seen in distressed companies or those with significant accumulated losses that have eroded shareholders' equity. The price-to-sales ratio and EV/EBITDA are also not available, meaning these alternative valuation metrics cannot be utilized to assess whether the stock is overvalued or undervalued relative to peers or historical norms. Regarding trading range, the 52-week high is $0.32 and the 52-week low is $0.23; without a specific current share price provided in the facts, the exact percentage position relative to this range cannot be calculated, but the narrow spread of 9 cents suggests low price volatility in recent periods. The beta is 0.13, indicating that the stock's price volatility is significantly lower than the broader market, moving only 13% as much as the market index, which characterizes the asset as a low-volatility instrument despite its financial distress indicators.

Growth & Income

The revenue growth year-over-year is -45.0%, while earnings growth is not available due to the negative earnings base; this contraction in revenue implies a shrinking top line that is directly contributing to the deep losses reported in the financial statements. Since the company is not a dividend payer, as indicated by the not available dividend yield and payout ratio, it does not distribute cash to shareholders but instead retains earnings which, in this case, are insufficient to cover losses. Consequently, the company reinvests its limited resources into maintaining its supply chain rather than paying dividends, a strategy typical for growth-stage or distressed firms attempting to stabilize operations before achieving profitability. The overall growth and income profile is characterized by significant revenue contraction and negative profitability metrics, with no current income generation for shareholders and a reliance on external capital or operational restructuring to reverse the -45.0% revenue decline.